Cardiomiopatía chagásica: parte 1
Contreras Z., Eduardo; Gómez M., Juan E; Zuluaga M., Sandra X.
Av. cardiol
; 30(3): 225-231, sept. 2010. graf
Artículo en Español | LILACS | ID: lil-607812
Documentos relacionados
Exercise training improves microvascular function in patients with Chagas heart disease: Data from the PEACH study.
A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina.
Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.
Correlation of TcII discrete typing units with severe chronic Chagas cardiomyopathy in patients from various Brazilian geographic regions.
Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.
Stroke in asymptomatic Trypanosoma cruzi-infected patients.
Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection.
Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.